Seelos Therapeutics, Inc. (NASDAQ:SEEL – Get Free Report) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 98,200 shares, a drop of 90.6% from the April 30th total of 1,040,000 shares. Based on an average daily trading volume, of 72,400 shares, the short-interest […]
/PRNewswire/ Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of.
Seelos Therapeutics Announces 1-for-8 Reverse Stock Split prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Wealth Effects LLC cut its stake in Seelos Therapeutics, Inc. (NASDAQ:SEEL – Free Report) by 93.7% in the fourth quarter, Holdings Channel reports. The firm owned 228,593 shares of the company’s stock after selling 3,376,653 shares during the period. Wealth Effects LLC’s holdings in Seelos Therapeutics were worth $318,000 as of its most recent filing […]